Novavax 904 Vaccine is produced based on influenza A viruses of type H9N2 and Newcastle NDV4 circulating in Iran and the Middle East region and has maximum antigenic similarity to the currently pathogenic viruses in the region. Therefore, it is used to prevent Newcastle disease and avian influenza of type H9N2 in flocks of broilers, layers, mothers, ancestors and turkeys.
Novavax 904 vaccine contains at least 10 log2 HAU of inactivated (killed) Newcastle disease virus strain V4 and 9 log2 HAU of inactivated (killed) avian influenza virus of the H9N2 type, which is capable of producing appropriate antibodies against Newcastle disease and avian influenza viruses after vaccination and providing active immunity against Newcastle disease and influenza A type H9 strains.
Novavax 904 vaccine combined with an oil adjuvant, is a strong antibody inducer, stable, and has a low viscosity that is easy to inject.
Packaging: 500 ml bottles (2000 doses).
Storage temperature: 2 to 8°C (protect from freezing).
Warning: In case of accidental injection, consult a doctor immediately.
آدرس: استان البرز، نظرآباد، شهرک صنعتی سپهر، بلوار کارآفرینان، خیابان بهمن غربی، مرکز رشد بهنود فارمد
تلفن: 45334191 026